Patent Assignment
Reel/Frame 059557/0968
Change of Name
Recorded: 2022-03-31
Pages: 2
Assignor
TRILLIUM THERAPEUTICS INC.
Executed: 2021-11-20
Assignee
TRILLIUM THERAPEUTICS ULC
2488 DUNWIN DRIVE, MISSISSAUGA, ON, L5L 1J9, CANADA
Covered Properties
(2)
Enhancement of CD47 Blockade Therapy with Dhfr Inhibitors
Application:
63/180,604 →
Enhancement of CD47 Blockade Therapy with Dhfr Inhibitors
Application:
63/253,125 →
Related Assignments
(3)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Sep 3, 2021
From: UGER, ROBERT ADAM; LIN, GLORIA HOI YING
To: TRILLIUM THERAPEUTICS INC.
Reel/Frame 057382/0449 →
Assignment of Assignor's Interest
Oct 15, 2021
From: UGER, ROBERT ADAM; LIN, GLORIA HOI YING
To: TRILLIUM THERAPEUTICS INC.
Reel/Frame 057805/0159 →
Assignment of Assignor's Interest
Jun 16, 2022
From: TRILLIUM THERAPEUTICS ULC
To: PF ARGENTUM IP HOLDINGS LLC
Reel/Frame 060221/0327 →